EcoDrugPlus

Leukotriene B4 Receptor

Ensembl ID : ENSPKIG00000022244
Gene Symbol: LTB4R
4 Cross references
79 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPKIG00000007918
Gene Symbol: LOC111854527
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSPKIG00000022227
Gene Symbol: LTB4R2A
1 Cross references
157 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSPKIG00000014589
Gene Symbol: KDM1A
1 Cross references
213 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSPKIG00000020353
Gene Symbol: LOC111841119
3 Cross references
210 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSPKIG00000000099
Gene Symbol: LOXL2
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor-Like

Ensembl ID : ENSPKIG00000009778
Gene Symbol: LOC111855185
3 Cross references
8 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPKIG00000020304
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPKIG00000019529
Gene Symbol: MST1R
2 Cross references
190 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSPKIG00000024903
Gene Symbol: LOC111840572
2 Cross references
122 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPKIG00000021674
Gene Symbol: MMP2
3 Cross references
207 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPKIG00000005040
Gene Symbol: MMP9
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).